Elevated CDC7 and MCM helicase expression levels in these cell models, especially the CDC7 direct target MCM2 subunit, correlate with higher proliferative rates observed in clinical prostate cancer with disease progression. The gene discussed is CDC7; the disease is Familial prostate cancer.